弥漫性血管内凝血(DIC)是涉及临床多学科的一个重要的病理生理过程,病情重,死亡率高。目前,其主要的治疗手段之一仍为肝素抗凝治疗。及时了解患者凝血和纤溶系统的活动情况是临床治疗所必须的,故应动态监测DIC的相关实验指标。急性DIC时凝血因子消耗减少,抗凝物质增多,凝血酶原 Diffuse intravascular coagulation (DIC) is an important pathophysiological process involved in clinical multidisciplinary, with severe illness and high mortality. At present, one of the main treatments is still heparin anticoagulant therapy. Timely understanding of patients with coagulation and fibrinolytic system activity is necessary for clinical treatment, it should be dynamically monitored DIC related experimental indicators. Acute DIC reduced consumption of coagulation factors, increased anticoagulant substances, prothrombin